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Abstract
Introduction: Whipple disease is a rare systemic infection caused by Tropheryma whippelii that
usually manifests with joint pain, weight loss, diarrhoea and abdominal pain. However, in some cases
the infection may involve other organs and tissues.
Case presentation: We report on a 44-year-old man with Whipple disease which led to renal
amyloidosis and end-stage renal failure. In this case, the patient was diagnosed with Whipple disease
and commenced on a 12-month trimetoprime-sulfametoxasole therapy with good result. Six months
after cessation of therapy the patient was readmitted to hospital due to signs of renal failure. An
urgent kidney biopsy was performed which revealed secondary amyloidosis. Despite intensive
immunosuppressive treatment, renal parameters gradually deteriorated and haemodialysis was
started eventually. Three months later the patient’s general condition dramatically worsened with
bloody diarrhoea, bilious vomiting and progressive malnutrition. The repeated endoscopic
examination confirmed severe recurrence of Whipple disease. Ceftriaxone and total parenteral
nutrition was started what greatly improved patient’s state.
Conclusions: To our knowledge based on systematic review, this is the first case report on
Whipple disease complicated by secondary amyloidosis and kidney failure maintained on permanent
renal replacement therapy. It is strongly suspected that the use of immunosuppressive treatment in
such cases may exacerbate the course of Whipple disease and cause life-threatening complications.
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Whipple disease is a rare chronic multisystem disorder
caused by a recently identified pathogen Tropheryma
whipelii belonging to order Actinomycetes [1]. The disease
mainly involves the gastrointestinal tract, but may also
affect central nervous system (up to 40% of cases), heart,
liver, lungs, bone marrow, skin, abdominal and peripheral
lymph nodes, as well as other tissues [2-4]. Clinically, the
classic symptoms of Whipple disease include joint pain,
weight loss, diarrhoea and abdominal pain. However,
some patients may report less specific ailments as a result
of other organs involvement. Herein, we report a case of a
young man with Whipple disease which led to renal
amyloidosis and loss of kidney function requiring
haemodialysis. We also indicate the potential negative
role of immunosuppressive therapy on the course of
Whipple disease.
Case presentation
A 44-year-old Polish Caucasian male, farmer, was admitted
tohospitaldue to3-month historyofhigh-gradefevers,loss
of weight, diarrhoea and joint pain. Physical examination
revealed swollen and reddened major joints of upper and
lower extremities. Laboratory and imaging examinations
excluded rheumatoid arthritis, ulceration and neoplasm.
Upper endoscopy revealed non-specific inflammation of
duodenum. Biopsy stains were not contributory. In view of
signs and symptoms a strong suspicion of Crohn’sd i s e a s e
was made and the patient was commenced on prednisone
30 mg per day with a good result.
Severalmonthslaterdiarrhoearelapsed,malaiseandlossof
weightwasnoticeable.Laboratorytestswereunremarkable
(including creatinine level) except for hemoglobin which
wasbelowreferencevalue(10g/dL).Upperendoscopywas
repeated and duodenum biopsy samples were collected.
Histochemical stains showed periodic acid-Schiff (PAS)-
positive particles in mucosa, which led to a diagnosis of
Whippledisease.Trimetoprime-sulfametoxasoleindoseof
960 mg twice per day was introduced. The patient was
recommended to continue the treatment for at least one
year. At that time diarrhoea subsided, test for proteinuria
was negative and all other renal parameters were within
normal limits.
One and half year later the patient was readmitted to the
hospital due to lower limbs oedema, weakness and
anorexia. Laboratory tests revealed nephritic proteinuria
(4-6 g/day), increased concentration of creatinine (1.2 mg/
dL) and erythrocyte sedimentation rate (115 mm), iron
deficiency anemia, decreased glomerular filtration rate
(GFR) (52 ml/min) and normal urea (42 mg/dL). A
kidney biopsy was performed which showed secondary
amyloidosis (Figure 1). Computed tomography scans
revealed enlargement of mesenteric and retroperitoneal
lymph nodes with high amount of lipids which was
suggestive of Whipple disease.
The patient received 1000 mg of cyclophosphamide,
20 mg of prednisone, and trimetoprime-sulfametoxasole.
A month later he received second pulse of cyclopho-
sphamide in dose of 400 mg. At this stage, creatinine
concentration was 2.7 mg/dL and urea 170 mg/dL. Within
next 3 weeks renal parameters markedly deteriorated and
renal replacement therapy was started.
Three months later the patient was hospitalized again due
to bloody diarrhoea, bilious vomiting, progressive malnu-
trition, anemia requiring erythrocyte transfusion and
intradialysis hypotension. He denied having fever, abdom-
inal pain or rectal tenesmus. On admission the patient was
in poor general condition with orthostatic hypotension of
60/0 mm Hg and blood pressure of 80/50 mm Hg in
recumbency. Heart rate was 64/min, body temperature was
36.6°C, BMI was 20. Muscular atrophy and malnutrition
were easily seen. At this stage the results of basic laboratory
testswereas follows: hemoglobin level 8.5 g/dL,hematocrit
25%, red blood cells counts 2.8 × 10
6/µL, white blood cells
counts 5.67 × 10
3/µL, lymphocyte counts 16%, serum total
protein 3.1 g/dL, albumin 1.6 g/dL, CRP 43 mg/dL and
ferritin 1839 ng/mL. Additional biochemical tests revealed
CD8 deficiency and abnormal CD4/CD8 ratio, decreased
concentration of IgA, IgM and IgG, elevated level of IgE,
reduced concentration of FT3 and testosterone, normal
value of TSH, cortisol, prolactin and fasting insulin. Urine
analysis detected proteinuria of 2.9 g/dL.
Upper endoscopy was performed, which showed sever
inflammation of post-bulbar duodenum with diffuse
Figure 1. Immunohistochemical staining of biopsy specimen –
glomerulus with amyloid-A (AA) deposits.
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fistula 60 cm from incisors. Histologic staining of collected
biopsy samples revealed blood extravasation with large
number of PAS-positive macrophages (Figure 2). This
pathomorphologic picture was suggestive of Whipple
disease. Subsequently, gastrointestinal series were per-
formed which did not confirm the presence of fistula.
On the basis of above findings a diagnosis of severe
exacerbation of Whipple disease was established. The
patient was started on ceftriaxone (1 × 2.0 g per day) and
total parenteral nutrition. Within few days of treatment
diarrhoea and hypotension subsided. Repeated gastro-
scopy showed tremendous improvement of lesions. In
view of difficult to manage nephritic proteinuria (daily
protein depletion of 10-20 g), we decided to perform
pharmacological nephrectomy and increase dehydration
during dialysis. The patient made excellent progress and
was discharged home 2 weeks later. He was recommended
to receive doxycyclin in dose of 2 × 100 mg for 12 months.
During the therapy daily diuresis decreased from 2000 ml
to 350 ml.
At 12-month follow-up, the patient presented in good
general condition with normal appetite and without
diarrhoea. He gained 5 kg (BMI increased to 21.8) and
his exercise tolerance improved so that he could get back
to work. Currently, the patient is on renal replacement
therapy 3 times a week with the use of arteriovenous
fistula. He receives doxycyclin regularly. Control com-
puted tomography scans showed marked reduction of
abdominal lymph nodes (maximum 2 cm in diameter)
(Figure 3).
Discussion
Whipple disease is a rare chronic multisystemic bacterial
disease that is potentially fatal, but responds dramatically
Figure 2. Duodenum mucosa with extended intestinal villi
(A) and numerous PAS-positive macrophages (B).
Immunohistochemical staining for CD68 – markers of
macrophages (C).
Figure 3. Computed tomography scans of the abdomen
shows enlargement of mesenteric and retroperitoneal lymph
nodes with high amount of lipids (exacerbation of Whipple
disease) (A). Marked reduction of lymph nodes on one-year
follow-up (B).
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Although the first description of Whipple disease comes
from 1907, this type of bowel infection is still a diagnostic
challenge for both clinicians and pathologists.
Clinical symptoms like diarrhoea, weight loss, abdominal
and joint pain are not pathognomonic for Whipple disease
and require differentiation with a long list of other
disorders, especially if neurological or ophthalmologic
manifestations occur. The basis of histopathological
recognition is the presence of foamy macrophages with
periodic acid-Schiff-positive inclusions in tissues such as
lamina propria [5]. Microbiological confirmation of
diagnosis is problematic. Culture of Tropheryma whipplei
has been established only once, in human fibroblast cell
lines from a heart valve inoculum what makes it
unavailable in clinical practice. Molecular-based diagnos-
tic techniques, like nucleotide sequencing and amplifica-
tion by reverse transcriptase-polymerase chain reaction
(rtPCR) of bacterial S ribosomal RNA, although highly
sensitive, are less specific, expensive and not available in
Poland. [6]. New diagnostic tools involving isolation of
bacteria from contaminated intestinal biopsies and
immunohistological detection need to be developed.
The case described here represents a very uncommon
presentation of Whipple disease, characterized by renal
amyloidosis leading to end stage renal failure. To
recapitulate available reports on amyloidosis in the course
of Whipple disease a PubMed literature search from 1960
to January 2009 was performed using the following search
strategy: (amyloidosis or amyloid or (renal failure) or (end
stage renal disease) or (end stage renal failure) or dialysis
or (renal replacement therapy)) and ((Whipple disease)
or (Whipple’s disease) or Whipple or Whipple’so r
(Whipple’s arthritis) or (Tropheryma whipplei) or
(Tropheryma) or (lipodystrophy)).
In addition, references from identified publications and
review papers on Whipple disease were also searched to
identify other reported cases. No type of article or language
restriction was set. Overall 107 papers on Whipple disease
were identified, of which 2 reports concerned deteriora-
tion of renal function [7-8], 1 report generalized amyloi-
dosis [9] and 5 reports renal amyloidosis (confirmed by
histopathology) [10-14]. None of the patients with
renal amyloidosis required dialysis or there was lack of
such data.
Conclusion
In presented case amyloidosis affected kidneys (confirmed
by renal biopsy) and manifested as nephritic syndrome
and rapidly progressive loss of renal function. The severe
relapse of the disease occurred after completion of 12-
month treatment with trimethoprim-sulfamethoxazole.
Trimethoprim-sulfamethoxazole is regarded as a first-line
antibiotic for Whipple disease but its efficacy may decrease
during long treatment due to mutations in the target gene
of sulfamethoxazole [15]. It cannot be excluded that such
failure treatment occurred in this case. Another important
issue is the implementation of immunosuppressive
treatment (cyclophosphamide and prednisone) due to
renal amyloidosis what probably led to severe relapse of
Whipple disease. Such negative association between
Whipple disease and immunosuppressive medications
was suggested previously by several authors [16-19]. After
administration of antibiotic therapy the patient’s general
condition improved dramatically, however, kidneys injury
was irreversible and the patient required renal replacement
therapy. To our knowledge based on systematic review,
this is the first case report on Whipple disease exacerbated
by immunosuppressive treatment, complicated by renal
amyloidosis and severe impairment of renal function.
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